State of Wisconsin Investment Board
ENGNW icon

State of Wisconsin Investment Board’s enGene Therapeutics Warrants ENGNW Stock Holding History

State of Wisconsin Investment Board’s Portfolio ENGNW Stock Details ENGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,049
Closed -$13.7K – 2427
2025
Q3 		$13.7K Sell
19,049
-4,521
-19% -$3.43K ﹤0.01% 2361
2025
Q2 		$18.6K Hold
23,570
– – ﹤0.01% 2304
2025
Q1 		$15.1K Hold
23,570
– – ﹤0.01% 2234
2024
Q4 		$20K Hold
23,570
– – ﹤0.01% 2250
2024
Q3 		$33.6K Hold
23,570
– – ﹤0.01% 2252
2024
Q2 		$32.8K Hold
23,570
– – ﹤0.01% 2269
2024
Q1 		$123K Hold
23,570
– – ﹤0.01% 2112
2023
Q4 		$20K Buy
+23,570
New +$18.1K ﹤0.01% 2327

Other funds holding ENGNW

FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

State of Wisconsin Investment Board's ENGNW Position: Q4 2025 in Review

State of Wisconsin Investment Board sold out of enGene Therapeutics Warrants (ENGNW) in Q4 2025, closing a stake of 19,049 shares — an estimated $13.7K sold.

State of Wisconsin Investment Board first reported a position in ENGNW in Q4 2023 and held it in 8 quarters. The position peaked at $123K in Q1 2024. 14 funds tracked by Wall St. Rank hold ENGNW as of Q4 2025.

  • State of Wisconsin Investment Board reported no remaining enGene Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 19,049 enGene Therapeutics Warrants shares in Q4 2025, an estimated $13.7K.
  • State of Wisconsin Investment Board first reported a position in enGene Therapeutics Warrants in Q4 2023 and held it in 8 quarters.
  • State of Wisconsin Investment Board's enGene Therapeutics Warrants position peaked at $123K in Q1 2024.
  • 14 funds tracked by Wall St. Rank held enGene Therapeutics Warrants as of Q4 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2025, filed 17 Feb 2026.